Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ASH logo ASH
Upturn stock ratingUpturn stock rating
ASH logo

Ashland Global Holdings Inc (ASH)

Upturn stock ratingUpturn stock rating
$50.13
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/06/2025: ASH (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

11 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $68.11

1 Year Target Price $68.11

Analysts Price Target For last 52 week
$68.11Target price
Low$44.84
Current$50.13
high$96.06

Analysis of Past Performance

Type Stock
Historic Profit -15.68%
Avg. Invested days 39
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/06/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.32B USD
Price to earnings Ratio -
1Y Target Price 68.11
Price to earnings Ratio -
1Y Target Price 68.11
Volume (30-day avg) 11
Beta 0.51
52 Weeks Range 44.84 - 96.06
Updated Date 06/30/2025
52 Weeks Range 44.84 - 96.06
Updated Date 06/30/2025
Dividends yield (FY) 3.27%
Basic EPS (TTM) -1.88

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -5.8%
Operating Margin (TTM) 6.68%

Management Effectiveness

Return on Assets (TTM) 2.28%
Return on Equity (TTM) -3.02%

Valuation

Trailing PE -
Forward PE 10.02
Enterprise Value 3635712924
Price to Sales(TTM) 1.19
Enterprise Value 3635712924
Price to Sales(TTM) 1.19
Enterprise Value to Revenue 1.87
Enterprise Value to EBITDA 54.26
Shares Outstanding 45694500
Shares Floating 45123810
Shares Outstanding 45694500
Shares Floating 45123810
Percent Insiders 1.07
Percent Institutions 95.99

Analyst Ratings

Rating 4
Target Price 68.11
Buy 1
Strong Buy 6
Buy 1
Strong Buy 6
Hold 4
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Ashland Global Holdings Inc

stock logo

Company Overview

overview logo History and Background

Ashland Global Holdings Inc. was founded in 1924 as Ashland Refining Company. It has evolved from a petroleum refiner to a global specialty chemical company, divesting its refining business over time.

business area logo Core Business Areas

  • Life Sciences: Provides solutions for pharmaceutical, nutraceutical, and personal care markets, focusing on excipients, controlled release technologies, and performance ingredients.
  • Specialty Additives: Develops and markets additives for coatings, adhesives, construction, and energy markets, enhancing product performance and sustainability.
  • Intermediates: Produces BDO (Butanediol) and associated products which are raw materials for manufacturing polymers, solvents and fine chemicals.

leadership logo Leadership and Structure

The company is led by Guillermo Novo (Chairman and CEO). It has a typical corporate structure with functional departments like finance, marketing, and operations.

Top Products and Market Share

overview logo Key Offerings

  • Benecelu2122: Cellulose ethers used as excipients in pharmaceutical formulations. Ashland has a significant market share in cellulose ethers for pharmaceutical applications. Competitors include Dow, Shin-Etsu Chemical.
  • Aquaflowu2122: Rheology modifiers for waterborne coatings. Ashland is a leading provider of rheology modifiers for the coatings industry. Competitors include BASF, Elementis Specialties.
  • Butanediol (BDO): Chemical intermediate for polymers and solvents with various end-use applications. Competitors are LyondellBasell, Genomatica.

Market Dynamics

industry overview logo Industry Overview

The specialty chemicals industry is characterized by innovation, customization, and a focus on performance. Demand is driven by various end-use markets like pharmaceuticals, coatings, and construction.

Positioning

Ashland is positioned as a specialty chemical company focused on high-value, differentiated products and solutions. Its competitive advantage lies in its technical expertise, customer relationships, and product portfolio.

Total Addressable Market (TAM)

The global specialty chemicals market is estimated to be worth hundreds of billions of dollars. Ashland targets specific segments within this TAM, positioning itself to capture growth in selected niche markets.

Upturn SWOT Analysis

Strengths

  • Strong product portfolio
  • Technical expertise and innovation
  • Customer relationships
  • Global presence
  • Focus on sustainability

Weaknesses

  • Dependence on raw material prices
  • Exposure to cyclical industries
  • Integration risks from acquisitions
  • Debt levels can be a concern

Opportunities

  • Growing demand for specialty chemicals in emerging markets
  • Increasing focus on sustainability and green chemistry
  • Potential for new product development
  • Acquisitions to expand product portfolio and geographic reach

Threats

  • Economic downturns
  • Increased competition
  • Fluctuations in raw material prices
  • Changes in regulations
  • Disruptive technologies

Competitors and Market Share

competitor logo Key Competitors

  • DD
  • IFF
  • EMN

Competitive Landscape

Ashland's competitive advantage lies in its specialized product offerings and customer-centric approach. Its disadvantages may include its smaller scale compared to larger competitors.

Major Acquisitions

Pharmachem

  • Year: 2017
  • Acquisition Price (USD millions): 660
  • Strategic Rationale: Expanded Ashland's presence in the nutraceuticals market.

Growth Trajectory and Initiatives

Historical Growth: Historical growth information is not available without real-time updates.

Future Projections: Future projections are not available without real-time updates.

Recent Initiatives: Recent initiatives are not available without real-time updates.

Summary

Ashland is a specialty chemical company with a focus on high-value products. Its strengths lie in its product portfolio, innovation, and customer relationships. Ashland needs to monitor raw material prices and economic conditions, but overall is stable. The company should continue focusing on expanding in the pharmaceutical sector through excipients.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings
  • Industry reports
  • Financial news sources
  • Ashland Global Holdings Inc Investor Relations

Disclaimers:

The data provided is for informational purposes only and should not be considered financial advice. Market share and financial data are estimates and may not be precise. All investment decisions should be made based on your own due diligence.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Ashland Global Holdings Inc

Exchange NYSE
Headquaters Wilmington, DE, United States
IPO Launch date 1983-04-06
Chairman & CEO Mr. Guillermo Novo
Sector Basic Materials
Industry Specialty Chemicals
Full time employees 3200
Full time employees 3200

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.